Acadia Pharmaceuticals to be part of S&P SmallCap 600, shares rise
** Shares of Acadia Pharmaceuticals ACAD.O up 9.35% at
$18.25 in extended trading
** S&P Dow Jones Indices after market close on Monday said
Acadia Pharmaceuticals will replace Independent Bank Group
IBTX.O in S&P Smallcap 600
** 13 of 19 brokerages rate ACAD "buy" or higher, 5 "hold"
and one "sell"; their median PT is $26 - LSEG data
** Including session moves, ACAD down 47% YTD
(Reporting by Anshuman Tripathy)
((Anshuman.Tripathy@thomsonreuters.com))
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP